Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.69, expectations were $1.55. Lantheus Holdings, Inc.
Source: insidermonkey.com
📰 Brian Markison News
Brian Markison News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brian Markison. Real-time updates on events, politics, business and more.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript May 2, 2024 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.69, expectations were $1.55. Lantheus Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]
Bob Marshall Brian Markison National Institute On Aging Alzheimer Association National Institute Perspective Therapeutics
Source: yahoo.com
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2023 Earnings Call Transcript
Operator: Good morning. Welcome to the Lantheus Fourth Quarter 2023 and Full Year 2023 Conference Call. This is your operator for todays call.
Source: insidermonkey.com
Lantheus Announces CEO Succession Plan
Lantheus Board Member and Pharmaceutical Industry Veteran Brian Markison Appointed Lantheus Chief Executive Officer, Effective March 1, 2024 Mary Anne Heino to Retire as Chief Executive Officer and...
Source: marketscreener.com
Lantheus Holdings Shares Touch 52-Week Low After Executive Change
By Colin Kellaher Lantheus Holdings shares moved lower and hit a new 52-week low on Tuesday after the radiopharmaceutical company said its chairman and chief...
Source: marketwatch.com
Lantheus Stock Falls 4% Over Announcement Of CEO Succession Plan
Radiopharmaceutical company, Lantheus Holdings's (LNTH) stock slipped 4 percent on Tuesday following the company's announcement that its Chief Executive Officer Mary Heino will be succeeded by Brian Markison, effective March 1.
Source: rttnews.com
RVL Completes Financial Restructuring
27.11.2023 - Athyrium Provides Capital to Support Long-Term Growth and Exchanges Outstanding Debt into Equity of Certain Reorganized Entities RVL Pharmaceuticals plc Ordinary Shares Expected to be Cancelled in 2024 BRIDGEWATER, N.J., Nov. 27, 2023 (GLOBE ...
United States Brian Markison Revitalid Pharmaceutical Corp Ptosis Association Pharmaceuticals Inc United States Bankruptcy Court
Source: wallstreet-online.de
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
Lender to Provide Incremental Liquidity to Support Long-Term Growth Senior Secured Lender to Exchange Outstanding Debt into Equity of the Reorganized Entities Business Operations at U.S. Subsidiaries to Continue as They Pursue Strategic Plan RVLP Ordinary Shares Expected to be Cancelled BRIDGEWATER, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (“RVL” or “the Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ
...
Source: yahoo.com
How to get your DC ready for driverless forklifts
Planning to introduce automated lift trucks in your DC? Here are some things to consider before you turn the robots loose.
United States Rocrich Markison Mick Mccormick Raymond Buena Franco John Rosenberger Martin Buena Franco
Source: dcvelocity.com
RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review
2022 includes $15,500 in licensing revenue recognized in connection with an amendment of our License Agreement with Santen, effective March 31, 2022, net of a $500 transaction fee expense classified... -Today at 06:51 am- MarketScreener
United States Lisam Wilson Brian Markison Alora Pharmaceuticals Site Communications Inc Globenewswire Inc
Source: marketscreener.com